The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy

Tian Wang,1,* Feng Lin,2,* Yujing Huang,2 Guowei Qian,2 Wenxi Yu,2 Haiyan Hu,2 Tong Ji,3 Lina Tang,2 Yang Yao2 1The Eighth People’s Hospital of Shanghai, Shanghai, People’s Republic of China; 2Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, Shanghai, People’s Republic of Chin...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wang T, Lin F, Huang Y, Qian G, Yu W, Hu H, Ji T, Tang L, Yao Y
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2022-10-01
coleção:	Cancer Management and Research
Assuntos:	anlotinib refractory metastatic osteosarcoma combination therapy
Acesso em linha:	https://www.dovepress.com/the-combination-of-anlotinib-and-gemcitabinedocetaxel-in-patients-with-peer-reviewed-fulltext-article-CMAR
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!